BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 10712410)

  • 1. LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study.
    Howard BV; Robbins DC; Sievers ML; Lee ET; Rhoades D; Devereux RB; Cowan LD; Gray RS; Welty TK; Go OT; Howard WJ
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):830-5. PubMed ID: 10712410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of lipoprotein lipids and apoproteins in predicting coronary heart disease in diabetic American Indians. The Strong Heart Study.
    Hu D; Jablonski KA; Sparling YH; Robbins DC; Lee ET; Welty TK; Howard BV
    Ann Epidemiol; 2002 Feb; 12(2):79-85. PubMed ID: 11880214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rising tide of cardiovascular disease in American Indians. The Strong Heart Study.
    Howard BV; Lee ET; Cowan LD; Devereux RB; Galloway JM; Go OT; Howard WJ; Rhoades ER; Robbins DC; Sievers ML; Welty TK
    Circulation; 1999 May; 99(18):2389-95. PubMed ID: 10318659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of coronary heart disease in a population with high prevalence of diabetes and albuminuria: the Strong Heart Study.
    Lee ET; Howard BV; Wang W; Welty TK; Galloway JM; Best LG; Fabsitz RR; Zhang Y; Yeh J; Devereux RB
    Circulation; 2006 Jun; 113(25):2897-905. PubMed ID: 16769914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic dyslipidemia.
    Kreisberg RA
    Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study.
    Lu W; Resnick HE; Jablonski KA; Jones KL; Jain AK; Howard WJ; Robbins DC; Howard BV
    Diabetes Care; 2003 Jan; 26(1):16-23. PubMed ID: 12502653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes and cardiovascular disease.
    Howard BV; Magee MF
    Curr Atheroscler Rep; 2000 Nov; 2(6):476-81. PubMed ID: 11122781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of high-density lipoprotein cholesterol with coronary heart disease risk across categories of low-density lipoprotein cholesterol: the atherosclerosis risk in communities study.
    Muntner P; Lee F; Astor BC
    Am J Med Sci; 2011 Mar; 341(3):173-80. PubMed ID: 21042169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians. The Strong Heart Study.
    Gray RS; Robbins DC; Wang W; Yeh JL; Fabsitz RR; Cowan LD; Welty TK; Lee ET; Krauss RM; Howard BV
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2713-20. PubMed ID: 9409247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary heart disease prevalence and its relation to risk factors in American Indians. The Strong Heart Study.
    Howard BV; Lee ET; Cowan LD; Fabsitz RR; Howard WJ; Oopik AJ; Robbins DC; Savage PJ; Yeh JL; Welty TK
    Am J Epidemiol; 1995 Aug; 142(3):254-68. PubMed ID: 7631630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.
    Abdullah SM; Defina LF; Leonard D; Barlow CE; Radford NB; Willis BL; Rohatgi A; McGuire DK; de Lemos JA; Grundy SM; Berry JD; Khera A
    Circulation; 2018 Nov; 138(21):2315-2325. PubMed ID: 30571575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of coronary heart disease events among asymptomatic persons with low low-density lipoprotein cholesterol MESA (Multi-Ethnic Study of Atherosclerosis).
    Blankstein R; Budoff MJ; Shaw LJ; Goff DC; Polak JF; Lima J; Blumenthal RS; Nasir K
    J Am Coll Cardiol; 2011 Jul; 58(4):364-74. PubMed ID: 21757113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes.
    Eliasson B; Gudbjörnsdottir S; Zethelius B; Eeg-Olofsson K; Cederholm J;
    Eur J Prev Cardiol; 2014 Nov; 21(11):1420-8. PubMed ID: 23774274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid measures for prediction of incident cardiovascular disease in diabetic and non-diabetic adults: results of the 8.6 years follow-up of a population based cohort study.
    Tohidi M; Hatami M; Hadaegh F; Safarkhani M; Harati H; Azizi F
    Lipids Health Dis; 2010 Jan; 9():6. PubMed ID: 20096127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma triglyceride level and mortality from coronary heart disease.
    Criqui MH; Heiss G; Cohn R; Cowan LD; Suchindran CM; Bangdiwala S; Kritchevsky S; Jacobs DR; O'Grady HK; Davis CE
    N Engl J Med; 1993 Apr; 328(17):1220-5. PubMed ID: 8464432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.